CME-548 (Oxford biomedica/Pfizer)

N/A

Report date: 2022/03/04 16:16:30

Base Information

Drug NameCME-548 (Oxford biomedica/Pfizer)
Drug Alias NameAnti-5T4 antibody5T4 monoclonal antibody conjugates (Oxford biomedica/Pfizer)5T4 MAb-toxinOBA1-H8CME-548
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Trophoblast glycoproteinDNA inhibitors
TargetsTrophoblast glycoproteinDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOxford Biomedica
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxford BiomedicaPfizer Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A